Biotech

All Articles

Lilly blog posts much more beneficial data on its every week blood insulin possibility

.On the heels of an FDA being rejected for its primary competing Novo Nordisk, Eli Lilly is actually...

IN 8bio halts phase 2 test, gives up half of workforce

.Just a couple of months after dosing the 1st individual in a stage 2 trial for newly diagnosed glio...

Lilly, Haya ink $1B biobuck obesity deal to look darker genome

.Eli Lilly's search for weight problems targets has led it to the dark genome. The Big Pharma has ac...

ArsenalBio raises $325M, pivots away from former lead resource

.Arsenal Biosciences is actually carrying on up. The tissue treatment business has actually added on...

Lilly- supported weight management biotech files IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has filed to d...

Aelis' marijuana use medication flunks phase 2b, steering Indivior to reassess $100M choice

.Aelis Farma's hopes of protecting an easy, favorable choice on a $100 thousand alternative remittan...

ProKidney stops phase 3 test certainly not needed for cell therapy permission

.ProKidney has ceased one of a pair of period 3 trials for its tissue treatment for kidney illness a...

Vaxcyte surges on 'sensational' 31-valent PCV win against Pfizer

.Vaxcyte introduced what analysts named "remarkable" stage 1/2 information for its 31-valent pneumoc...

Recursion's brain health condition trial presents little evidence of efficiency

.Recursion has discovered via a very early exam of its tech-enabled technique to medication discover...

Acepodia, Pfizer click on together for chemistry-based cell treatment

.Call it a case of good chemistry: Acepodia, a biotech based on Nobel Prize-winning science, is beco...